Publications by authors named "Huiping Wan"

Claim this Profile
C
Construction of sodium alginate/ginkgo biloba polysaccharide based films embedded with ginkgo biloba extract and its application in postharvest quality stabilization of sweet cherries.
Keyu Sun, Ziwuzhen Wang, Wenxin Xiang, Shuhong Ye, Huiping Wan

Food Chem· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and functional properties of conjugates of rice protein with exopolysaccharides from ps-5 by Maillard reaction.
Yuguang Zhao, Shuhong Ye, Huiping Wan, Xingxing Zhang, Mingqi Sun

Food Sci Nutr· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fosaprepitant versus aprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: a multicenter, randomized, double-blind, double-simulated, positive-controlled phase III trial.
Zhonghan Zhang, Yunpeng Yang, Ping Lu, Xiaoqin Li, Jianhua Chang, Hong Wang, Huiping Wan

Ann Transl Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biosimilar candidate IBI305 plus paclitaxel/carboplatin for the treatment of non-squamous non-small cell lung cancer.
Yunpeng Yang, Bin Wu, Linian Huang, Meiqi Shi, Yunpeng Liu, Lijun Wang, Mengzhao Wang, Huiping Wan, Huaqing Wang, Jinliang Wang

Transl Lung Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral injection of dendritic cells overexpressing interleukin‑12 inhibits melanoma growth.
Weirong Yao, Yingliang Li, Lin Zeng, Xiquan Zhang, Zhiyong Zhou, Huiping Wan

Oncol Rep· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UNC0638, a G9a inhibitor, suppresses epithelial‑mesenchymal transition‑mediated cellular migration and invasion in triple negative breast cancer.
Xiang-Rong Liu, Li-Hua Zhou, Jian-Xin Hu, Li-Min Liu, Hui-Ping Wan

Mol Med Rep· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An insertion/deletion polymorphism within the promoter of EGLN2 is associated with susceptibility to colorectal cancer.
Chaoyang Li, Lanjun Feng, Luwei Niu, Teng Teng Li, Bin Zhang, Huiping Wan, Kai Wang

Int J Biol Markers· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cod skin peptide reduces chemotherapy-induced toxicity in gastric cancer patients.
Li-Ping Wu, Xiao-Fei Hu, Hui-Ping Wan, Yan-Min Yu, Jian-Hua Yu

Asia Pac J Clin Nutr· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer.
Yan Sun, Ying Cheng, Xuezhi Hao, Jie Wang, Chengping Hu, Huiping Wan

BMC Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor gene polymorphism (-634G/C) and breast cancer risk.
Weirong Yao, Rongzeng Yan, Lin Ma, Huiping Wan, Yanmin Yu

Tumour Biol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD243 gene polymorphism significantly associated with breast cancer susceptibility.
Weirong Yao, Rongzeng Yan, Lin Ma, Huiping Wan, Yanmin Yu

Tumour Biol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre randomised trial comparing weekly paclitaxel + S-1 with weekly paclitaxel + 5-fluorouracil for patients with advanced gastric cancer.
Dingzhi Huang, Yi Ba, Jianping Xiong, Nong Xu, Zhao Yan, Huiping Wan, Meiling Wang

Eur J Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety analysis of weekly paclitaxel plus S-1 versus paclitaxel plus 5-fluorouracil/calcium folinate as first-line therapy in advanced gastric cancer: a multicenter open random phase II trial.
Ting Deng, Nong Xu, Jian-Ping Xiong, Zhao Yan, Zhi-Xiang Zhuang, Hui-Ping Wan, Mei-Ling Wang

J Chemother· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A phase II prospective randomized controlled trial of weekly paclitaxel combined with S-1 or fluorouracil for advanced gastric carcinoma].
Ding-zhi Huang, Jian-ping Xiong, Nong Xu, Zhao Yan, Zhi-xiang Zhuang, Hui-ping Wan, Mei-Ling Wang

Zhonghua Zhong Liu Za Zhi· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis